Market Overview

Smith & Nephew's Exclusive OXINIUM Material for Hip Replacement Implants Chosen for Premium Reimbursement in Japan

Share:

OXINIUM Oxidized Zirconium, the patented advanced bearing material from Smith & Nephew (NYSE: SNN, LSE: SN) Orthopaedics Division, has been awarded a C1 premium reimbursement classification in Japan for use in hip replacement surgery.

The decision by the Central Medical Insurance Committee comes three years after it awarded Smith & Nephew with Japan's first-ever premium price reimbursement for an orthopaedic implant—for the use of OXINIUM material in total knee replacement implants. Smith & Nephew is the only orthopaedic medical device company to have been awarded C1 reimbursement for both hip and knee replacement implants.

Posted-In: News FDA

 

Related Articles

View Comments and Join the Discussion!

Gerald Celente on Obama's Budget: ‘They're Bankrupting the Country!'

Forex - NZD/USD up in U.S. trade